Explore combinatorial therapies with weight-modulating antidiabetics (GLP-1 RAs or dual GLP/GIP RAs, SGLT2 inhibitors, metformin) in obese diabetics
It also may help in improving concentration, maintaining fertility, antiaging, boosting energy levels, converting fat to energy and mood elevation
Key points: Both medications cause similar gastrointestinal side effects, most commonly nausea, diarrhoea, and constipation In the head-to-head trial, liraglutide had double the discontinuation rate of semaglutide (27.6% vs 13.5%) Side effects tend to occur early in treatment and improve over time Wegovy has cardiovascular outcome data (SELECT trial) that liraglutide does not Dosing and practical differences Injection frequency One of the most significant practical differences is how often you inject
Peptides were resolved on an ACQUITY UPLC HSS C 18 column (1.8 m, 2.1 50 mm) with mobile phase A (water + 0.1% formic acid) and B (acetonitrile + 0.1% formic acid), 2 l injections, 0.3 ml min 1
In SUSTAIN 6, the largest trial investigating semaglutide, with the longest duration reported to date in subjects with high cardiovascular risk, mean pulse rate increases of 2.1 and 2.4 bpm were reported with semaglutide 0.5 and 1.0 mg, respectively, versus no change with placebo
This led to normalized sleep duration and decreased nocturnal awakenings
